Valuation: Sagittarius Life Science Corp

Market Cap 2.97B 89.93M 80.13M 73.3M 66.75M 126M 8.5B 129M 881M 352M 4.5B 338M 330M 14.2B P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 2.17B 65.63M 58.48M 53.49M 48.71M 91.82M 6.2B 94.3M 643M 257M 3.28B 246M 241M 10.36B EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
08-14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-16 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
13/08/25 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
15/05/25 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
13/03/25 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/11/24 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/08/24 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
15/05/24 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/03/24 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
14/11/23 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
14/08/23 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
1 day-2.87%
1 week-2.65%
Current month-3.83%
1 month-6.38%
3 months-8.24%
6 months-21.01%
Current year-14.23%
1 week 40.85
Extreme 40.85
46.2
1 month 40.85
Extreme 40.85
47.5
Current year 40.85
Extreme 40.85
67
1 year 40.85
Extreme 40.85
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
150
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 15/11/2019
Director TitleAgeSince
Chairman - 29/04/2004
Director/Board Member - 17/06/2015
Director/Board Member - 29/04/2004
Change 5-day change 1-year change 3-year change Capi.($)
-2.87%-2.65%-13.21%-0.68% 92.58M
-1.58%+1.36%+8.82%-14.04% 275B
-0.72%+2.26%+18.19%-2.68% 84.58B
-2.10%+2.44%-13.28%+18.09% 49.49B
+0.69%+7.90%+6.59%-4.78% 35.66B
+0.37%-7.96%+24.81%-2.44% 33.54B
+0.36%+3.62%-5.07%-4.66% 30.62B
-2.47%+1.68%+4.34%-25.65% 29.97B
-12.40%-16.93%-3.70%+51.32% 29.45B
+1.29%+6.79%+15.41%+13.95% 29.44B
Average -1.97%+2.07%+4.29%+2.84% 59.81B
Weighted average by Cap. -1.74%+4.19%+7.85%-4.08%

Financials

2024 2025
Net sales 468M 14.15M 12.61M 11.54M 10.51M 19.8M 1.34B 20.34M 139M 55.42M 708M 53.12M 51.98M 2.24B 346M 10.47M 9.33M 8.54M 7.77M 14.65M 990M 15.05M 103M 41M 524M 39.31M 38.46M 1.65B
Net income -48.53M -1.47M -1.31M -1.2M -1.09M -2.05M -139M -2.11M -14.38M -5.75M -73.49M -5.51M -5.39M -232M -49.56M -1.5M -1.34M -1.22M -1.11M -2.1M -142M -2.15M -14.69M -5.87M -75.06M -5.63M -5.51M -237M
Net Debt -150M -4.54M -4.05M -3.7M -3.37M -6.36M -429M -6.53M -44.48M -17.79M -227M -17.05M -16.69M -717M -803M -24.3M -21.66M -19.81M -18.04M -34M -2.3B -34.92M -238M -95.15M -1.22B -91.22M -89.26M -3.84B
Projected Income Statement - Annual - Sagittarius Life Science Corp
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
06/11/26 NT$44.00 -2.87% 200,625
05/11/26 NT$45.30 +2.37% 74,282
04/11/26 NT$44.25 +0.45% 58,492
03/11/26 NT$44.05 -2.00% 41,156
02/11/26 NT$44.95 -1.75% 64,181
  1. Stock Market
  2. Stocks
  3. 3205 Stock